Schedule 13G ownership disclosure

Verona Pharma plc

Security class unavailable · CUSIP: G9337X139

Event date: 2023-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
30,271,952
Percent of class
4.7300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-24-000023
Form type
SC 13G
Filer
Verona Pharma plc
CIK
CIK 1657312
Filed
Feb 08, 2024
Reporting period
Dec 29, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub